Drug Topics - May 12, 2008 - (Page 58) 58 DRUG TOPICS MAY 12, 2008 www.drugtopics.com Home Care CMS’ prices for round one of DMEPOS competitive bidding raising concerns Sandra Levy he home care industry is very concerned about the Centers for Medicare & Medicaid Services’ announcement that it will pay on average 26% less than current levels for 10 product categories included in the first round of competitive bidding for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). The first round of the program begins July 1 in Charlotte, Cincinnati, Cleveland, Dallas, Kansas City, Miami, Orlando, Pittsburgh, Riverside, and San Juan. Bill Popomaronis, R.Ph., VP, long term and home healthcare pharmacy services for the National Community Pharmacists Association, is worried that many providers may be forced to go out of Jim Walsh worries business. “Twenty six percent is a big percentage. A that many small small supplier may say, ‘I’m going to bid low.’ But providers may sometimes you can pick up business and go out of be hurt by CMS' DMEPOS business. If you pick up business too fast or don't competitive bidding program. have the financial resources and staffing to address the increase in business, there could be cash flow problems. I’m concerned that the big guys are going to go after the little guys in this case. What if access is affected? They (CMS) have already cut down the number of suppliers significantly.” Popomaronis believes that although CMS said that 64% of the winning bidders were small suppliers, community pharmacies were disenfranchised in the bidding program. “Community pharmacies are also small suppliers, but we’re defined as large suppliers. The average community pharmacy based on 2007 data does about $3.5 million in sales. If you own more than one pharmacy, your total aggregate business says whether you’re a small supplier or not. In an aggregate, they’d be above the small supplier definition. The feedback we’re getting is that community pharmacies were not bidding in large numbers mainly because of the high cost of accreditation and the fact that they are defined as large suppliers. My question to CMS is, ‘How many community pharmacies are represented in the 64% of small suppliers they are talking about?’ I would guess not many.” Jim Walsh, president and general counsel of the VGM Group, Inc., echoed Popomaronis' sentiments. “The lower the levels of service funded by Medicare, the lower the number of providers there will be who wish to be in that business,” he said, adding, “their (CMS) public relations spin that 64% of the ‘awards’ went to small T businesses is misleading. What they are saying is, if you do a head count of the number of businesses, it may be that 64% of the ones who were awarded contracts fall into the small business category. That doesn’t mean that they will do 64% of the business. It's more likely they will do much, much less than that.” The Council for Quality Respiratory Care chairman Peter Kelly warned that “the magnitude of current and pending Medicare cuts will make the oxygen benefit unsustainable and the impact on beneficiaries dangerously unpredictable.” Walsh agreed with Kelly’s prediction, saying that Medicare equipment suppliers will be forced to make weekly or monthly deliveries to patients instead of on an as-needed basis. Complex rehab products, which Walsh pointed out require a high level of employee training and relatively high compensation for credentialled clinicians and technicians, will also be negatively impacted by the price reduction. “This will result in higher costs in rehab facilities and hospitals,” Walsh asserted. Walsh foresees that diabetes patients will be forced to pick up their supplies or receive them in the mail less frequently than when they were delivered by their provider and that they may not receive the brand of supplies that they prefer. Meanwhile, The American Association for Homecare said it has heard from DME providers in many states that they have been improperly disqualified and thereby removed by CMS from the bidding process. “We’re alarmed about the volume of the mistakes made by Medicare’s contractor tasked with evaluating bids and implementing of the bidding program,” said Heather Allan, executive director of the Florida Association of Medical Equipment Services. “A process this obviously flawed needs to be stopped, analyzed, and corrected, if it can’t be done away with altogether. If it's not, the ramifications for Medicare beneficiaries and small businesses alike will be much worse than we anticipated.” Finally, Walsh added, “We know of a joint venture of two large regional hospital chains in the home medical equipment business who submitted a package to bid and were told they didn't meet the financial criteria.” Additional information on the DMEPOS competitive bidding program is available at www.cms.hhs.gov/ CompetitiveAcqforDMEPOS/. http://www.drugtopics.com http://www.cms.hhs.gov/CompetitiveAcqforDMEPOS/ http://www.cms.hhs.gov/CompetitiveAcqforDMEPOS/
Table of Contents Feed for the Digital Edition of Drug Topics - May 12, 2008 Drug Topics - May 12, 2008 Contents Latebreakers Letters R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors There's a New School of Thought on Use of Beta-Blockers for Hypertension Cover Story Guest Spot Letters Clinical Practice Special Report Professional Practice Broad Label for New Leukemia Therapy Looks Promising Treating Asthma During Pregnancy Safer than Not, Says New Guide In the Pipeline Clinical Q&A APhA Leader's Plan to Leave Office Takes Center Stage at its Conference Policies Passed at a Glance Giving a Talk to the Community? Check Out These Materials This Foundation has Funds to Spare JP at Large Cover Story: Employers and R.Ph.S: A Win-Win Combo FDA's Ilisa Bernstein Discusses Pharmacy Affairs Legal Q&A Manufacturers Unleash a Rash of Poison Ivy Treatments Are OTC Cold Remedies Safe for Kids? Probiotics are All the Rage: How You Can Capitalize on It CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns CVS Caremark's Mentoring Program Recruits and Retains R.Ph.s Antibiotic Resistance Among Community Pathogens Technology Update New Products Advertisers Index Classified Viewpoint Drug Topics - May 12, 2008 Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page Cover1) Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page Cover2) Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page 1) Drug Topics - May 12, 2008 - Contents (Page 2) Drug Topics - May 12, 2008 - Contents (Page 3) Drug Topics - May 12, 2008 - Contents (Page 4) Drug Topics - May 12, 2008 - Contents (Page 4A) Drug Topics - May 12, 2008 - Contents (Page 4B) Drug Topics - May 12, 2008 - Contents (Page 5) Drug Topics - May 12, 2008 - Latebreakers (Page 6) Drug Topics - May 12, 2008 - Latebreakers (Page 7) Drug Topics - May 12, 2008 - Latebreakers (Page 8) Drug Topics - May 12, 2008 - Latebreakers (Page 9) Drug Topics - May 12, 2008 - Letters (Page 10) Drug Topics - May 12, 2008 - Letters (Page 11) Drug Topics - May 12, 2008 - R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors (Page 12) Drug Topics - May 12, 2008 - R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors (Page 13) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 14) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 15) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 16) Drug Topics - May 12, 2008 - Cover Story (Page HSE1) Drug Topics - May 12, 2008 - Guest Spot (Page HSE2) Drug Topics - May 12, 2008 - Guest Spot (Page HSE3) Drug Topics - May 12, 2008 - Guest Spot (Page HSE4) Drug Topics - May 12, 2008 - Letters (Page HSE5) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE6) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE7) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE8) Drug Topics - May 12, 2008 - Special Report (Page HSE9) Drug Topics - May 12, 2008 - Special Report (Page HSE10) Drug Topics - May 12, 2008 - Special Report (Page HSE11) Drug Topics - May 12, 2008 - Professional Practice (Page HSE12) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 17) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 18) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 19) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 20) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 21) Drug Topics - May 12, 2008 - Treating Asthma During Pregnancy Safer than Not, Says New Guide (Page 22) Drug Topics - May 12, 2008 - Treating Asthma During Pregnancy Safer than Not, Says New Guide (Page 23) Drug Topics - May 12, 2008 - In the Pipeline (Page 24) Drug Topics - May 12, 2008 - In the Pipeline (Page 24A) Drug Topics - May 12, 2008 - In the Pipeline (Page 24B) Drug Topics - May 12, 2008 - Clinical Q&A (Page 25) Drug Topics - May 12, 2008 - Clinical Q&A (Page 26) Drug Topics - May 12, 2008 - Clinical Q&A (Page 27) Drug Topics - May 12, 2008 - Clinical Q&A (Page 28) Drug Topics - May 12, 2008 - Clinical Q&A (Page 29) Drug Topics - May 12, 2008 - Clinical Q&A (Page 30) Drug Topics - May 12, 2008 - Clinical Q&A (Page 31) Drug Topics - May 12, 2008 - Clinical Q&A (Page 32) Drug Topics - May 12, 2008 - Clinical Q&A (Page 33) Drug Topics - May 12, 2008 - Policies Passed at a Glance (Page 34) Drug Topics - May 12, 2008 - Policies Passed at a Glance (Page 35) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36A) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36B) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 37) Drug Topics - May 12, 2008 - JP at Large (Page 38) Drug Topics - May 12, 2008 - JP at Large (Page 39) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 40) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 41) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 42) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 43) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 44) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 45) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 46) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 47) Drug Topics - May 12, 2008 - FDA's Ilisa Bernstein Discusses Pharmacy Affairs (Page 48) Drug Topics - May 12, 2008 - FDA's Ilisa Bernstein Discusses Pharmacy Affairs (Page 49) Drug Topics - May 12, 2008 - Legal Q&A (Page 50) Drug Topics - May 12, 2008 - Legal Q&A (Page 51) Drug Topics - May 12, 2008 - Legal Q&A (Page 52) Drug Topics - May 12, 2008 - Manufacturers Unleash a Rash of Poison Ivy Treatments (Page 53) Drug Topics - May 12, 2008 - Are OTC Cold Remedies Safe for Kids? (Page 54) Drug Topics - May 12, 2008 - Are OTC Cold Remedies Safe for Kids? (Page 55) Drug Topics - May 12, 2008 - Probiotics are All the Rage: How You Can Capitalize on It (Page 56) Drug Topics - May 12, 2008 - Probiotics are All the Rage: How You Can Capitalize on It (Page 57) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 58) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 59) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 60) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 61) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 62) Drug Topics - May 12, 2008 - CVS Caremark's Mentoring Program Recruits and Retains R.Ph.s (Page 63) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 64) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 65) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 66) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 67) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 68) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 69) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 70) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 71) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 72) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 73) Drug Topics - May 12, 2008 - Technology Update (Page 74) Drug Topics - May 12, 2008 - Technology Update (Page 75) Drug Topics - May 12, 2008 - Technology Update (Page 76) Drug Topics - May 12, 2008 - Advertisers Index (Page 77) Drug Topics - May 12, 2008 - Advertisers Index (Page 78) Drug Topics - May 12, 2008 - Classified (Page 79) Drug Topics - May 12, 2008 - Classified (Page 80) Drug Topics - May 12, 2008 - Classified (Page 81) Drug Topics - May 12, 2008 - Classified (Page 82) Drug Topics - May 12, 2008 - Classified (Page 83) Drug Topics - May 12, 2008 - Classified (Page 83A) Drug Topics - May 12, 2008 - Classified (Page 83B) Drug Topics - May 12, 2008 - Viewpoint (Page 84) Drug Topics - May 12, 2008 - Viewpoint (Page Cover3) Drug Topics - May 12, 2008 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.